These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23465777)

  • 21. Antigenic and genetic analyses of foot-and-mouth disease virus type A isolates for selection of candidate vaccine strain reveals emergence of a variant virus that is responsible for most recent outbreaks in India.
    Jangra RK; Tosh C; Sanyal A; Hemadri D; Bandyopadhyay SK
    Virus Res; 2005 Sep; 112(1-2):52-9. PubMed ID: 16022900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of one-step multiplex RT-PCR method for simultaneous detection and differentiation of foot-and-mouth disease virus serotypes O, A, and Asia 1 circulating in Vietnam.
    Le VP; Lee KN; Nguyen T; Kim SM; Cho IS; Van Quyen D; Khang DD; Park JH
    J Virol Methods; 2011 Jul; 175(1):101-8. PubMed ID: 21550367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNA structure disrupting G320-T transversion within the short fragment of the 5' untranslated region prevents rescue of infectious foot-and-mouth disease virus.
    Mohapatra JK; Pandey LK; Pattnaik B
    J Virol Methods; 2014 Feb; 196():100-3. PubMed ID: 24269793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Engineering infectious foot-and-mouth disease virus in vivo from a full-length genomic cDNA clone of the A/AKT/58 strain.
    Bai X; Li P; Cao Y; Li D; Lu Z; Guo J; Sun D; Zheng H; Sun P; Liu X; Luo J; Liu Z
    Sci China C Life Sci; 2009 Feb; 52(2):155-62. PubMed ID: 19277527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complete genome sequence of a potential foot-and-mouth disease virus serotype O vaccine strain from Bangladesh.
    Al Amin M; Ali MR; Alam ASMRU; Siddique MA; Rahaman MM; Sultana M; Hossain MA
    Arch Virol; 2020 Sep; 165(9):2119-2122. PubMed ID: 32591914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequences outside that of residues 93-102 of 3A protein can contribute to the ability of foot-and-mouth disease virus (FMDV) to replicate in bovine-derived cells.
    Ma X; Li P; Bai X; Sun P; Bao H; Lu Z; Cao Y; Li D; Chen Y; Qiao Z; Liu Z
    Virus Res; 2014 Oct; 191():161-71. PubMed ID: 25116389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a hamster kidney cell line expressing stably T7 RNA polymerase using retroviral gene transfer technology for efficient rescue of infectious foot-and-mouth disease virus.
    Zheng H; Tian H; Jin Y; Wu J; Shang Y; Yin S; Liu X; Xie Q
    J Virol Methods; 2009 Mar; 156(1-2):129-37. PubMed ID: 19095010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sindbis virus replicase-based DNA vaccine construct encoding FMDV-specific multivalent epitope gene: studies on its immune responses in guinea pigs.
    Dar PA; Ganesh K; Nagarajan G; Sarika S; Reddy GR; Suryanarayana VV
    Scand J Immunol; 2012 Oct; 76(4):345-53. PubMed ID: 22702835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune responses of recombinant adenovirus co-expressing VP1 of foot-and-mouth disease virus and porcine interferon alpha in mice and guinea pigs.
    Du Y; Dai J; Li Y; Li C; Qi J; Duan S; Jiang P
    Vet Immunol Immunopathol; 2008 Aug; 124(3-4):274-83. PubMed ID: 18511133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular characterization of serotype Asia-1 foot-and-mouth disease viruses in Pakistan and Afghanistan; emergence of a new genetic Group and evidence for a novel recombinant virus.
    Jamal SM; Ferrari G; Ahmed S; Normann P; Belsham GJ
    Infect Genet Evol; 2011 Dec; 11(8):2049-62. PubMed ID: 21983559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Custom-engineered chimeric foot-and-mouth disease vaccine elicits protective immune responses in pigs.
    Blignaut B; Visser N; Theron J; Rieder E; Maree FF
    J Gen Virol; 2011 Apr; 92(Pt 4):849-59. PubMed ID: 21177923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA vaccination against foot-and-mouth disease via electroporation: study of molecular approaches for enhancing VP1 antigenicity.
    Kim SA; Liang CM; Cheng IC; Cheng YC; Chiao MT; Tseng CJ; Lee F; Jong MH; Tao MH; Yang NS; Liang SM
    J Gene Med; 2006 Sep; 8(9):1182-91. PubMed ID: 16927362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of suitability of two serotype A candidate vaccine strains for inclusion in FMD vaccine in India.
    Mohapatra JK; Hemadri D; Rao TV; Sreenivasa BP; Subramaniam S; Sanyal A; Periyasamy TR; Singh NK; Pattnaik B; Venkataramanan R
    Vet Microbiol; 2008 Sep; 131(1-2):65-72. PubMed ID: 18394827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alpha interferon is a powerful adjuvant for a recombinant protein vaccine against foot-and-mouth disease virus in swine, and an effective stimulus of in vivo immune response.
    Cheng G; Zhao X; Yan W; Wang W; Zuo X; Huang K; Liu Y; Chen J; Wang J; Cong W; Liu M; Gao H; Chen J; Lu Y; Zheng Z
    Vaccine; 2007 Jul; 25(28):5199-208. PubMed ID: 17555848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diversity and transboundary mobility of serotype O foot-and-mouth disease virus in East Africa: implications for vaccination policies.
    Balinda SN; Sangula AK; Heller R; Muwanika VB; Belsham GJ; Masembe C; Siegismund HR
    Infect Genet Evol; 2010 Oct; 10(7):1058-65. PubMed ID: 20619358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Construction and characterization of 3A-epitope-tagged foot-and-mouth disease virus.
    Ma X; Li P; Sun P; Bai X; Bao H; Lu Z; Fu Y; Cao Y; Li D; Chen Y; Qiao Z; Liu Z
    Infect Genet Evol; 2015 Apr; 31():17-24. PubMed ID: 25584768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
    Grubman MJ
    Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of foot-and-mouth disease virus (FMDV) serotype O virus-like-particles (VLPs) vaccine and evaluation of its potency.
    Mohana Subramanian B; Madhanmohan M; Sriraman R; Chandrasekhar Reddy RV; Yuvaraj S; Manikumar K; Rajalakshmi S; Nagendrakumar SB; Rana SK; Srinivasan VA
    Antiviral Res; 2012 Dec; 96(3):288-95. PubMed ID: 23043941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A positively charged lysine residue at VP2 131 position allows for the enhanced adaptability of foot-and-mouth disease virus serotype A in BHK-21 cells.
    Biswal JK; Mohapatra JK; Bisht P; Subramaniam S; Sanyal A; Pattnaik B
    Biologicals; 2015 Jan; 43(1):71-8. PubMed ID: 25439090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross-inhibition to heterologous foot-and-mouth disease virus infection induced by RNA interference targeting the conserved regions of viral genome.
    Liu M; Chen W; Ni Z; Yan W; Fei L; Jiao Y; Zhang J; Du Q; Wei X; Chen J; Liu Y; Zheng Z
    Virology; 2005 May; 336(1):51-9. PubMed ID: 15866070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.